{"transactions":[{"id":843772,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-13T18:00:09.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.24,"expiration_date":"2026-12-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193125-26-106547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526106547/ownership.xml","form_type":"4"}},{"id":843771,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-13T18:00:09.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":1.24,"value":74400.0,"ownership":{"direct":true},"balance_after":823576,"source":{"system":"sec-edgar","filing":"0001193125-26-106547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526106547/ownership.xml","form_type":"4"}},{"id":921519,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":180000,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921518,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921517,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":44366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original grant of 133,100 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original grant of 133,100 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44366},"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921516,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":16104,"price":4.24,"value":68280.96,"ownership":{"direct":true},"balance_after":763576,"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921515,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":54866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,507 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":779680,"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":1284385,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T18:00:15.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2025 such that the option is fully vested on January 31, 2029."}],"balance_after":200000,"derivative":{"exercise_price":3.06,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-25-013849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017025013849/ownership.xml","form_type":"4"}},{"id":1284384,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T18:00:15.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":10500,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000950170-25-013849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017025013849/ownership.xml","form_type":"4"}},{"id":1284383,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T18:00:15.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":44367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":44366,"derivative":{"underlying":"Common Stock","underlying_shares":44367},"source":{"system":"sec-edgar","filing":"0000950170-25-013849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017025013849/ownership.xml","form_type":"4"}},{"id":1284382,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T18:00:15.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":16102,"price":3.06,"value":49272.12,"ownership":{"direct":true},"balance_after":717307,"source":{"system":"sec-edgar","filing":"0000950170-25-013849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017025013849/ownership.xml","form_type":"4"}},{"id":1284381,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T18:00:15.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":10500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects shares received upon the satisfaction of performance criteria and time-vesting requirements associated with previously granted performance restricted stock units (\"PSUs\")."}],"balance_after":733409,"source":{"system":"sec-edgar","filing":"0000950170-25-013849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017025013849/ownership.xml","form_type":"4"}},{"id":1284380,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T18:00:15.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":44367,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,334 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":722909,"source":{"system":"sec-edgar","filing":"0000950170-25-013849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017025013849/ownership.xml","form_type":"4"}},{"id":1661333,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:31:35.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028."}],"balance_after":200000,"derivative":{"exercise_price":4.16,"expiration_date":"2034-01-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-24-010973","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017024010973/ownership.xml","form_type":"4"}},{"id":1661332,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-02-02T21:31:35.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":44367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":88733,"derivative":{"underlying":"Common Stock","underlying_shares":44367},"source":{"system":"sec-edgar","filing":"0000950170-24-010973","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017024010973/ownership.xml","form_type":"4"}},{"id":1661331,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-02T21:31:35.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":15843,"price":3.8449,"value":60914.7507,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022."}],"balance_after":670208,"source":{"system":"sec-edgar","filing":"0000950170-24-010973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017024010973/ownership.xml","form_type":"4"}},{"id":1661330,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-02T21:31:35.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":44367,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,680 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":686051,"source":{"system":"sec-edgar","filing":"0000950170-24-010973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000095017024010973/ownership.xml","form_type":"4"}},{"id":2035645,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T18:30:56.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":186300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027."}],"balance_after":186300,"derivative":{"exercise_price":4.63,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":186300},"source":{"system":"sec-edgar","filing":"0000899243-23-003607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000089924323003607/doc4.xml","form_type":"4"}},{"id":2035644,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T18:30:56.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":133100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026."}],"balance_after":133100,"derivative":{"underlying":"Common Stock","underlying_shares":133100},"source":{"system":"sec-edgar","filing":"0000899243-23-003607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000089924323003607/doc4.xml","form_type":"4"}},{"id":2416215,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T17:15:35.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":181000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022."}],"balance_after":181000,"derivative":{"exercise_price":7.14,"expiration_date":"2032-01-30","underlying":"Common Stock","underlying_shares":181000},"source":{"system":"sec-edgar","filing":"0000899243-22-004184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000089924322004184/doc4.xml","form_type":"4"}},{"id":2888428,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-01T16:52:05.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":148850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021."}],"balance_after":148850,"derivative":{"exercise_price":73,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":148850},"source":{"system":"sec-edgar","filing":"0000899243-21-003869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000089924321003869/doc4.xml","form_type":"4"}},{"id":2994511,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-11-03T20:08:54.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":33004,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33004},"source":{"system":"sec-edgar","filing":"0000899243-20-030330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000089924320030330/doc4.xml","form_type":"4"}},{"id":2994510,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-11-03T20:08:54.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-20-030330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000089924320030330/doc4.xml","form_type":"4"}},{"id":2994509,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-11-03T20:08:54.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":133004,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."}],"balance_after":633004,"source":{"system":"sec-edgar","filing":"0000899243-20-030330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000089924320030330/doc4.xml","form_type":"4"}}]}